SynthesisBritish journal of clinical pharmacology2013

Incidence and risk of hypertension with a novel multi-targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta-analysis.

Wei-Xiang Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.